Aurinia Pharmaceuticals, Inc. (AUPH)

14.84 +0.44 (+3.06%) USD  |  NASDAQ  |  Feb 23, 16:00
14.97 +0.13 (+0.88%) After-Hours: 16:56
More

Aurinia Pharmaceuticals SG&A Expense (% of Quarterly Revenues)

SG&A Expense (% of Quarterly Revenues) Chart

View SG&A Expense (% of Quarterly Revenues) for AUPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (% of Quarterly Revenues) Range, Past 5 Years

View SG&A Expense (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (% of Quarterly Revenues) Benchmarks

View SG&A Expense (% of Quarterly Revenues) Benchmarks
Start Trial
Oncolytics Biotech, Inc. --
Edesa Biotech, Inc. --
Lexaria Bioscience Corp. Upgrade
Xenon Pharmaceuticals, Inc. Upgrade
ProMIS Neurosciences, Inc. --